Actively Recruiting
Ocular Microbiome and Immune System in Dry Eyes
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-04-01
600
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
S
Stiftung OPOS
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objectives of this study are the characterization of the ocular microbiome as well as of the local immune system in participants with and without dry eye disease. Secondary objectives are the identification of differences in the ocular microbiome as well as in the immune system between participants with and without dry eye disease to ultimately find associations between the ocular microbiome and the immune system in dry eye disease.
CONDITIONS
Official Title
Ocular Microbiome and Immune System in Dry Eyes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to sign informed consent
- 18 years of age or older
You will not qualify if you...
- Not willing or able to sign informed consent
- Younger than 18 years
- Recent (3 month) history of use of systemic and/or topical antibiotics
- Usage of medical eye drops (Lacrycon and other moisturizing eye drops are allowed)
- Recent (3 month) history of ocular surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Ophthalmology, Inselspital
Bern, Switzerland, 3010
Actively Recruiting
Research Team
M
Martin Zinkernagel, Prof. Dr. Dr.
CONTACT
D
Denise Zysset, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here